Your browser doesn't support javascript.
loading
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Moorman, Anthony V; Barretta, Emilio; Butler, Ellie R; Ward, Eleanor J; Twentyman, Katie; Kirkwood, Amy A; Enshaei, Amir; Schwab, Claire; Creasey, Tom; Leongamornlert, Daniel; Papaemmanuil, Elli; Patrick, Pip; Clifton-Hadley, Laura; Patel, Bela; Menne, Tobias; McMillan, Andrew K; Harrison, Christine J; Rowntree, Clare J; Marks, David I; Fielding, Adele K.
Afiliación
  • Moorman AV; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK. anthony.moorman@ncl.ac.uk.
  • Barretta E; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Butler ER; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Ward EJ; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Twentyman K; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Kirkwood AA; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, UK.
  • Enshaei A; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Schwab C; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Creasey T; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Leongamornlert D; Sanger Institute, Cambridge, UK.
  • Papaemmanuil E; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Patrick P; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, UK.
  • Clifton-Hadley L; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, UK.
  • Patel B; Department of Haematology, Queen Mary University of London, London, UK.
  • Menne T; Department of Haematology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • McMillan AK; Department of Haematology, Nottingham University Hospital NHS Trust, Nottingham, UK.
  • Harrison CJ; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Rowntree CJ; Department of Haematology, Cardiff And Vale University Health Board, Cardiff, UK.
  • Marks DI; Department of Haematology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Fielding AK; UCL Cancer Institute, London, UK.
Leukemia ; 36(3): 625-636, 2022 03.
Article en En | MEDLINE | ID: mdl-34657128
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido